Has Tal Rubinstein, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,526 in general payments to Tal Rubinstein, MD across 58 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tal Rubinstein, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tal Rubinstein, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tal Rubinstein, MD

Ophthalmology · Cary, NCNPI 1376830760

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,668 of the $5,526 with a category attached, or 66.4%. Amgen accounts for 87.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $2,324 and has fallen 92.4% since, to $177 in 2025.

$5,526in general payments, 2019–2025

Across 58 payments — averaging $95.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$5K
Alcon$242
Biotissue Holdings Inc.$164
Genentech USA, Inc.$135
Spark Therapeutics, Inc.$92
Mallinckrodt Enterprises LLC$34
plus $22 from 1 others

What the payments were for

Speaking & faculty fees$3,66866%
Food & beverage$1,85834%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	50	$4,837
Alcon	2	$242
Biotissue Holdings Inc.	2	$164
Genentech USA, Inc.	1	$135
Spark Therapeutics, Inc.	1	$92
Mallinckrodt Enterprises LLC	1	$34
Kerecis Limited	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TEPEZZA$4,304
Erivedge$135
Prokera$132
AmnioGraft$132
ARGOS$128
Clareon$114

How this compares

$5,526 in reported general payments places this provider in the 80th percentile of 588 ophthalmology providers in North Carolina.

See all ophthalmology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$208,490

Medicare patients

321

Services billed

2,771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RestasisCyclosporine	27	$16,755
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	330	$3,675
Prednisolone Acetate	65	$1,771
ErythromycinErythromycin Base	88	$1,036
Tobramycin-DexamethasoneTobramycin/Dexamethasone	20	$1,014
MoxifloxacinMoxifloxacin Hcl	51	$897
Doxycycline Hyclate	35	$218
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim	24	$178
Methylprednisolone	25	$105
Cephalexin	23	$82
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	19	$71
Lorazepam	18	$16

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Cary

Preeya GuptaRaleigh$1.8M
Julie WoodwardDurham$1M
Rajiv ShahWinston Salem$909K
Lejla VajzovicDurham$681K
Karl StonecipherGreensboro$653K
Terry KimDurham$605K
Keith WalterWinston Salem$397K
Leon HerndonDurham$230K
Thomas MundorfCharlotte$220K
Glenn JaffeDurham$218K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →